Clinical Trials Browser

Phase 1/2 × Mucopolysaccharidosis I × Paclitaxel × Clear all

NCT03411161 2021-05-25

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Mucopolysaccharidosis I, Triple Negative Breast Neoplasms